Subscribe to RSS
DOI: 10.1055/s-2007-967952
Simple and General Synthesis of α-(p-Nitroaryl) Derivatives of Alanine and Serine
Publication History
Publication Date:
07 February 2007 (online)
![](https://www.thieme-connect.de/media/synlett/200703/lookinside/thumbnails/10.1055-s-2007-967952-1.jpg)
Abstract
α-(p-Nitroaryl)alanine and α-(p-nitroaryl)serine alkyl esters are efficiently synthesized via oxidative nucleophilic substitution of hydrogen in nitroarenes with carbanions of protected alanine and serine.
Key words
amino acids - nucleophilic aromatic substitution - arenes - carbanions
-
2a
Gante J. Angew. Chem., Int. Ed. Engl. 1994, 33: 1699 -
2b
Bellier B.McCort-Tranchenpain I.Ducos B.Danascimento S.Meudal H.Noble F.Garbay C.Roques BP. J. Med. Chem. 1997, 40 - 3
Schneider JP.Kelly JW. Chem. Rev. 1995, 95: 2169 - 4
Cativiela C.Diaz-de-Villegas MD. Tetrahedron: Asymmetry 1998, 9: 3517 -
5a
Najera C. Synlett 2002, 1388 -
5b
Mossel E.Formaggio F.Crisma M.Toniolo C.Broxterman QB.Boesten WH.Kamphius J.Quaedflieg PJLM.Temussi P. Tetrahedron: Asymmetry 1997, 8: 1305 -
6a
Bryant SD.Guerrini R.Salvadori S.Bianchi C.Tomatis R.Atilla M.Lazarus LH. J. Med. Chem. 1997, 40: 2579 -
6b
Johannesson P.Erdelyi M.Lindenberg G.Frandberg P.-A.Nyberg F.Karlen A.Hallberg A. J. Med. Chem. 2004, 47: 6009 - 7
Wilson MW.Ault-Justus SE.Hodges JC.Rubin JR. Tetrahedron 1999, 55: 1647 -
8a
Davis FA.Lee S.Zhang H.Fanelli DL. J. Org. Chem. 2000, 65: 8704 -
8b
Vachal P.Jacobsen EN. Org. Lett. 2000, 6: 867 -
9a
Mąkosza M.Staliński K. Chem. Eur. J. 1997, 3: 2025 -
9b
Mąkosza M.Staliński K. Tetrahedron 1998, 54: 8797 -
9c
Mąkosza M.Staliński K. Pol. J. Chem. 1999, 73: 151 -
10a
Mąkosza M.Surowiec M. Tetrahedron 2003, 59: 6261 -
10b
Mąkosza M.Surowiec M.Paszewski M. ARKIVOC 2004, (ii): 172 -
10c
Mąkosza M.Kamieńska-Trela K.Paszewski M.Bechcicka M. Tetrahedron 2005, 61: 11952 -
11a
Belokon YN.Kochetkov KA.Churkina TD.Ikonnikow NS.Larionov OV.Harutynyan SR.Vyskocil S.North M.Kagan HB. Angew. Chem. Int. Ed. 2001, 40: 1948 -
11b
O’Donnell MJ.Bennett WD.Bruder WA.Jacobson WN.Knuth K.LeClef B.Polt RL.Bordwell FG.Mrozach SR.Cripe TA. J. Am. Chem. Soc. 1988, 110: 8520 - 12
Hoppe D.Beckmann L. Liebigs Ann. Chem. 1979, 12: 2066 - 13
O’Donnell MJ.Polt RL. J. Org. Chem. 1982, 47: 2663 - 14
Laaziri A.Uziel J.Juge S. Tetrahedron: Asymmetry 1998, 9: 437 -
15a
O’Donnel MJ.Wu S. Tetrahedron: Asymmetry 1992, 3: 59 -
15b
Belokon YN.Kochetkov KA.Churkina TD.Ikonnikov NS.Chesnokov AA.Larionov OV.Parmar VS.Kumar R.Kagan HB. Tetrahedron: Asymmetry 1992, 3: 851 -
15c
Ooi T.Takeuchi M.Kameda M.Maruoka K. J. Am. Chem. Soc. 2000, 122: 5228 -
16a
Jew S.-S.Lee Y.-J.Lee J.Kang MJ.Jeong B.-S.Lee J.-H.Yoo M.-S.Kim MJ.Choi S.-H.Ku J.-M.Park H.-G. Angew. Chem. Int. Ed. 2004, 43: 2382 -
16b
Lee YJ.Lee J.Kim M.-J.Kim T.-S.Park H.-G.Jew S.-S. Org. Lett. 2005, 7: 1557 - 18
Casas J.Najera C.Sansano JM.Gonzales J.Saa JM.Vega M. Tetrahedron: Asymmetry 2001, 12: 699 - 19
Stolz D.Pick R.Kazmaier U. Synlett 2006, 1616 -
20a
Bartoli G.Marcantoni E.Bosco M. Tetrahedron Lett. 1989, 30: 2129 -
20b
Bartoli G.Marcantoni E.Bosco M. Tetrahedron Lett. 1988, 29: 2251 - 21
Moskalev N.Mąkosza M. Chem. Commun. 2001, 1248
References and Notes
Summer Trainee from Higher Chemical College, Moscow, Russian Federation.
17
General Procedure for Oxidative Nucleophilic Substitution (Compounds 2a-8a and 2b-5b):
To a stirred solution of t-BuOK (1.5 mmol) in THF (10 mL) cooled to -78 °C under an argon atmosphere were added dropwise a solution of nitroarene (2 mmol) and the respective protected alanine ester (1 mmol) dissolved in DMF (2 mL). The resulting dark mixture was stirred at this temperature for 30 min and treated with DDQ (1.2 mmol) in THF (2 mL). The dark brown solution was stirred for 5 min at - 78 °C, then the mixture was allowed to reach r.t. (ca. 30 min) and was then filtered trough a ca. 5 cm pad of silica gel and eluted subsequently with EtOAc-hexane. Evaporation of the solvents gave a residue that was purified by column chromatography (2b-5b) and recrystallized from EtOH or directly hydrolyzed (2a-8a).
General Procedure for Oxidative Nucleophilic Substitution (Compounds 2c-11c):
To a stirred solution of nitroarene (2 mmol), 4-carboethoxy-2-phenyl-2-oxazoline (1c; 1 mmol) in THF (10 mL) and DMF (2 mL) cooled to -40 °C
[22]
was added 1 M solution of t-BuOK (1.1 mmol) dropwise during 15 min. The resulting dark colored mixture was stirred at this temperature for 30 min and treated with DDQ (1.1 mmol) in THF (2 mL). After 5 min the reaction mixture was allowed to reach r.t. (ca. 15 min) and treated with 5% aq solution of NH4Cl (30 mL). Extraction with CH2Cl2, drying of the organic phase with anhyd Na2SO4 and evaporation of the solvent gave a residue that was purified by column chromatography (EtOAc-hexane).
Procedures for HydrolysisFor Compounds 2a-8a; General Procedure: The crude ONSH product (2a-8a, 1 mmol), was dissolved in EtOH (5 mL) and treated with concd aq HCl (1 mL). The solution was stirred for 24 h at r.t. and then evaporated to dryness. This residue was dissolved in CH2Cl2 (25 mL) and extracted with H2O (3 × 25 mL). The aqueous layer was basified with solid Na2CO3 to pH 9 and extracted with CH2Cl2 (3 × 50 mL). The combined extracts were dried and evaporated to dryness. Purification by column chromatography gave the desired products 2d-8d.
For Compounds 2b-5b; Typical Procedure: A stirred solution of 2b (1 mmol), p-TosOH (0.1 mmol) in MeCN (5 mL) and 100% formic acid (5mL) was cooled to 0-4 °C in an ice-bath and treated with 30% aq H2O2 (10 mmol). The mixture was stirred at this temperature for further 3 h and then at r.t. for 48 h. After this time an excess of solid Na2SO3 was added and the solvents were evaporated under reduced pressure. The residue was dissolved in H2O (10 mL) and treated with solid Na2CO3 to pH 9. Extraction with CH2Cl2 (3 × 25 mL), and purification by column chromatography gave pure 2e.
For Compounds 2c-11c; Typical Procedure: Compound 9c was dissolved in 6 M aq HCl (3 mL) and THF (1.5 mL) and the mixture was then heated at reflux for 48 h. After cooling to r.t., the solvents were removed on rotary vapor. This residue was dissolved in EtOH (1.5 mL), treated with propylene oxide (1 mL) and stirred for 2 h at r.t. The resulting solid, being the free amino acid, was filtered off and washed with cold EtOH and Et2O.
Physical Data of Selected ProductsCompound 2b: mp 96-99 °C. IR (KBr): 2984, 2941, 1732, 1583, 1521, 1349, 1238, 1094, 897, 764 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.20 (d, J = 1.9 Hz, 1 H), 8.14 (d, J = 2.3 Hz, 1 H), 8.11 (s, 1 H), 5.08 (sept, J = 6.3 Hz, 1 H), 3.53-3.62 (m, 2 H), 3.30-3.39 (m, 2 H), 1.89 (s, 3 H), 1.17 (dd, J = 0.9, 6.3 Hz, 6 H). 13C NMR (100 MHz, CDCl3): δ = 170.1, 167.7, 147.5, 147.3, 133.8, 131.0, 125.1, 121.1, 70.4, 69.5, 40.5, 33.5, 21.3, 21.8, 20.6. MS (ESI): m/z = 389 [M + H]+.
Compound 4b: mp 108-109 ºC. IR (KBr): 3101, 2983, 1726, 1599, 1523, 1356, 1243, 1096, 848, 722 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.89 (d, J = 1.8 Hz, 1 H), 7.87 (d, J = 8.8 Hz, 1 H), 7.61 (dd, J = 2.0, 8.7 Hz, 1 H), 5.04 (sept, J = 6.3 Hz, 1 H), 3.58-3.74 (m, 2 H), 3.38-3.52 (m, 2 H), 1.77 (s, 3 H), 1.22 (d, J = 6.2 Hz, 3 H), 1.13 (d, J = 6.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 171.0, 170.2, 150.0, 146.5, 130.0, 127.0, 125.4, 125.3, 70.8, 69.6, 40.3, 34.4, 22.5, 21.4, 21.2. MS (ESI): m/z = 389 [M + H]+.
Compound 5b: mp 123-125 ºC. IR (KBr): 3111, 3043, 2982, 2234, 1723, 1592, 1530, 1355, 1246, 1096, 927, 848 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.29 (d, J = 8.3 Hz, 1 H), 8.27 (d, J = 2.2 Hz, 1 H), 8.00 (dd, J = 2.2, 8.8 Hz, 1 H), 5.03 (sept, J = 6.3 Hz, 1 H), 3.60-3.76 (m, 2 H), 3.39-3.54 (m, 2 H), 1.80 (s, 3 H), 1.22 (d, J = 6.3 Hz, 3 H), 1.11 (d, J = 6.3 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 171.1, 170.6, 151.6, 147.2, 133.9, 131.4, 125.4, 115.1, 107.9, 70.8, 70.0, 40.5, 34.6, 22.6, 21.5, 21.2. MS (ESI): m/z = 380 [M + H]+.
Compound 2c: oil. IR (film): 2982, 1734, 1641, 1529, 1357, 1257, 1098, 694 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.07-8.12 (m, 2 H), 7.90 (d, J = 8.5 Hz, 1 H), 7.74 (d, J = 1.9 Hz, 1 H), 7.44-7.59 (m, 4 H), 5.38 (d, J = 8.9 Hz, 1 H), 4.40 (d, J = 8.9 Hz, 1 H), 4.26 (dq, J = 5.2, 7.2 Hz, 2 H), 1.25 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.7, 166.3, 147.4, 147.2, 132.4, 129.5, 128.9, 128.5, 127.7, 126.4, 126.0, 125.0, 80.1, 76.20, 62.8, 13.9. MS (ESI): m/z = 375 [M + H]+.
Compound 4c: mp 82-84 ºC. IR (KBr): 3104, 2978, 1738, 1634, 1528, 1355, 1248, 1101, 976, 692 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.28 (d, J = 2.3 Hz, 1 H), 8.16 (dd, J = 2.3, 8.8 Hz, 1 H), 8.05-8.12 (m, 2 H), 8.03 (d, J = 8.8 Hz, 1 H), 6.50-7.60 (m, 1 H), 7.43-7.51 (m, 2 H), 5.66 (d, J = 9.2 Hz, 1 H), 4.35 (d, J = 9.2 Hz, 1 H), 4.26-4.35 (m, 1 H), 4.13-4.22 (m, 1 H), 1.21 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 169.7, 167.0, 147.9, 147.7, 132.4, 132.4, 129.8, 128.9, 128.5, 126.5, 124.7, 122.0, 80.1, 76.1, 62.9, 13.9. MS (ESI): m/z = 375 [M + H]+.
Compound 3c: mp 134-136 ºC. IR (KBr): 3038, 2988, 2973, 2238, 1736, 1641, 1533, 1348, 1247 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.34 (d, J = 8.8 Hz, 1 H), 8.07-8.13 (m, 3 H), 7.29 (dd, J = 1.9, 8.8 Hz, 1 H), 7.65-7.61 (m, 1 H), 7.46-7.51 (m, 2 H), 5.40 (d, J = 8.9 Hz, 1 H), 4.43 (d, J = 8.9 Hz, 1 H), 4.26 (q, J = 7.2 Hz, 2 H), 1.25 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.3, 166.8, 149.1, 147.8, 133.5, 132.6, 131.2, 128.9, 128.6, 126.1, 125.8, 114.7, 108.4, 80.0, 76.1, 63.1, 29.7, 13.9. MS (ESI): m/z = 366 [M + H]+.
Compound 10c: mp 80-83 ºC. IR (KBr): 3109, 2981, 1736, 1643, 1521, 1345, 1246, 1022, 801, 740 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.06-8.10 (m, 2 H), 7.89 (dd, J = 2.2, 8.3 Hz, 1 H), 7.81 (d, J = 8.3 Hz, 1 H), 7.72 (d, J = 2.2 Hz, 1 H), 7.52-7.57 (m, 1 H), 7.41-7.48 (m, 2 H), 5.56 (d, J = 9.1 Hz, 1 H), 4.25-4.34 (m, 1 H), 4.19 (d, J = 9.1 Hz, 1 H), 4.06-4.15 (m, 1 H), 3.93 (s, 3 H), 1.17 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.5, 166.6, 155.7, 148.6, 138.7, 132.2, 128.8, 128.4, 127.8, 126.9, 116.2, 105.2, 78.2, 76.5, 62.1, 56.0, 14.0. MS (ESI): m/z = 371 [M + H]+.
Compound 4d: oil. IR (film): 2984, 1737, 1524, 1350, 1187, 1098, 766, 747 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.23 (d, J = 2.4 Hz, 1 H), 8.16 (dd, J = 2.4, 8.6 Hz, 1 H), 8.03 (d, J = 8.6 Hz, 1 H), 4.20 (q, J = 7.2 Hz, 2 H), 2.06 (br s, 2 H), 1.72 (s, 3 H), 1.22 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 175.1, 148.5, 147.4, 133.5, 128.0, 125.4, 121.9, 61.9, 60.3, 25.3, 13.9. MS (ESI): m/z = 273 [M + H]+.
Compound 5d: mp 50-52 ºC. IR (KBr): 3384, 3366, 3019, 3042, 2236, 1724, 1528, 1350, 1172, 1019 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.30 (d, J = 8.8 Hz, 1 H), 8.22 (d, J = 2.2 Hz, 1 H), 8.03 (dd, J = 2.2, 8.8 Hz, 1 H), 4.23 (q, J = 7.2 Hz, 2 H), 2.11 (br s, 2 H), 1.73 (s, 3 H), 1.27 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 174.0, 151.9, 147.3, 133.1, 131.1, 125.4, 115.0, 107.8, 62.3, 60.4, 28.1, 14.0. MS (ESI): m/z = 264 [M + H]+.
Compound 6d: oil. IR (film): 3384, 3112, 2985, 1738, 1529, 1355, 1193, 811, 742 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.07 (ddd, J = 0.7, 2.4, 8.6 Hz, 1 H), 7.87-7.93 (m, 2 H), 4.20 (qd, J = 1.3, 7.2 Hz, 2 H), 2.05 (br s, 1 H), 1.67 (s, 3 H), 1.22 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 174.8, 159.6 (d, J
C-F = 249.4 Hz), 147.9 (d, J
C-F = 9.5 Hz), 139.2 (d, J
C-F = 12.9 Hz), 127.6 (d, J
C-F = 5.2 Hz), 119.4 (d, J
C-F = 3.5 Hz), 111.4 (d, J
C-F = 27.6 Hz), 61.8, 58.2. MS (ESI): m/z = 257 [M + H]+.
Compound 7d: oil. IR (film): 3385, 2984, 1736, 1577, 1531, 1360, 1101, 864 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.24 (d, J = 8.3 Hz, 1 H), 7.72 (d, J = 8.3 Hz, 1 H), 4.21 (dd, J = 1.7, 7.2 Hz, 2 H), 2.19 (br s, 1 H), 1.74 (s, 3 H), 1.24 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 173.9, 167.0, 142.6, 135.1, 119.4, 62.6, 62.1, 25.9, 14.0. MS (ESI): m/z = 274 [M + H]+.
Compound 2e: oil. IR (film): 3383, 2983, 1736, 1733, 1524, 1350, 1096, 767, 747 cm-1. 1H NMR (400 MHz, CDCl3): δ = 8.23 (d, J = 2.4 Hz, 1 H), 8.15 (dd, J = 2.4, 8.8 Hz, 1 H), 8.02 (d, J = 8.8 Hz, 1 H), 5.07 (sept, J = 6.2 Hz, 1 H), 2.15 (br s, 2 H), 1.72 (s, 3 H), 1.19 (d, J = 6.2 Hz, 6 H). 13C NMR (100 MHz, CDCl3): δ = 174.4, 148.4, 147.4, 133.4, 128.1, 125.4, 121.9, 69.4, 60.3, 25.2, 20.40, 20.39. MS (ESI): m/z = 287 [M + H]+.
Compound 2f: mp >350 °C(dec.). IR (film): 3215, 3080, 2517, 1649, 1607, 1521, 1390, 134 cm-1. 1H NMR (400 MHz, D2O-DCl): δ = 8.26 (d, J = 9.1 Hz, 2 H), 7.69 (d, J = 9.1 Hz, 2 H), 4.42 (d, J = 12.1 Hz, 1 H), 4.19 (d, J = 12.1 Hz, 1 H). 13C NMR (100 MHz, D2O-DCl): δ = 170.5, 148.5, 139.3, 127.6, 124.7, 66.8, 63.8. MS (ESI): m/z = 227 [M + H]+.
With 2-chloronitrobenzene, the reaction was carried out at -78 °C.